NT5E and intrahepatic cholangiocarcinoma: For example, circHMGCS1-016 was uncovered to reshape immune surroundings in intrahepatic cholangiocarcinoma (ICC) by controlling the levels of CD73 and GAL-8 through interaction with miR-1236-3p [28].